# Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases (93.083)

Source: https://welltoldgrants.com/programs/93-083-prevention-of-disease-disability-and-death-through/  
Publisher: Well Told Grants. Data: USAspending.gov and Grants.gov, updated November 7, 2026.

Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases is run by Department of Health and Human Services. From fiscal 2021 to 2025 it awarded $58.2 million in 30 grants, about $1.9 million per award.

## Objectives

The purpose of this program is to strengthen capacity to prevent disease, disability, and death through immunization and control of respiratory and related diseases. The specific objectives may include, but are not limited to: 1. Increase the population of children and adults who are free from respiratory infectious disease complications. 2. Strengthen local, state, and national capacity for the early detection, investigation, response and control of respiratory infections in order to accelerate early recognition of respiratory threats and to mitigate the impact of their spread. 3. Control the rise in antimicrobial resistant respiratory infections in the community. 4. Strengthen prevention and control of respiratory infections in institutional settings, such as health care facilities and workplaces. 5. Reduce mortality from pneumonia and other severe respiratory infections. 6. Strengthen capacity for early detection, investigation, response, and control of respiratory infectious threats.

## Funding by fiscal year

| Year | Amount | Awards |
|---|---|---|
| 2021 | $26.4 million | 9 |
| 2022 | $17.0 million | 5 |
| 2023 | $11.4 million | 12 |
| 2024 | $0 | 0 |
| 2025 | $3.4 million | 11 |

## Largest recipients

| Recipient | State | Amount |
|---|---|---|
| Council of Medical Specia | Illinois | $40.4 million |
| Post-Acute and Long-Term Care Medical Association, Inc. | Maryland | $7.1 million |
| National Health Laboratory Service |  | $3.1 million |
| All India Institute of Medical Sciences |  | $1.0 million |
| American Cancer Society, Inc | Georgia | $900,000 |
| State of Alaska Department of Health | Alaska | $785,760 |
| Chinese Center for Disease Control and Prevention |  | $773,500 |
| American Academy of Pediatrics | Illinois | $500,000 |
| Triangle Biotechnology, Inc | North Carolina | $300,000 |
| New Jersey Department of Health | New Jersey | $300,000 |
| Florida Department of Health | Florida | $300,000 |
| HDT Bio Corp | Washington | $299,984 |
| Eitr Biologics, Inc. | California | $299,794 |
| Electronucleics Inc | California | $275,760 |
| Dotquant LLC | Washington | $275,482 |
| Vaccinate Your Family, Inc | Connecticut | $275,000 |
| Virongy Biosciences Inc | Virginia | $273,181 |
| Carogen Corp | Connecticut | $263,991 |
| Serplus Technology, LLC | California | $259,613 |
| Sunomix Therapeutics | California | $252,010 |

## Open opportunities

- [NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-100-nih-cdc-and-fda-small-business-innovation-research/), closes April 5, 2027
- [Expanded Surveillance for Pediatric Infectious Diseases](https://welltoldgrants.com/grants/rfa-ip-27-035-expanded-surveillance-for-pediatric-infectious-diseases/), closes not stated